Numerate
San Bruno
About Numerate
Numerate is a group of cutting-edge scientists and engineers trying to solve very difficult problems at the interface of data science, machine learning, cloud scale analytics and medicinal chemistry. We have developed a computational platform that can predict how a potential drug will behave in the lab and the body. We use this platform to process large spaces of chemistry while searching for therapies for some of the world’s most important diseases, such as, obesity, heart failure, Alzheimer’s, and Huntington’s disease. Our platform makes the drug development process cheaper, faster, and results in higher success rates than traditional approaches.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.4M
- Funding stage: M&A
- Last round: Grant (Aug 2019)
- Website: numerate.com
- Phone: (650)472-0632
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Machine Learning, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/numerate-94466 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.